Stephen Moses: Difference between revisions

(7 intermediate revisions by 2 users not shown)

Line 55:

|DOI=10.1111/j.1464-410X.2005.05810.x

|accessdate=

}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an HIV prevention method.<ref>{{REFweb

}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an [[HIV]] prevention method.<ref>{{REFweb

|last=World Health Organization

|first=

Line 65:

== Interests ==

According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.<ref name='moses-bio'>{{REFweb

According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/[[HIV]] transmission.<ref name='moses-bio'>{{REFweb

|last=Moses

|first=Stephen

|title=Dr. Stephen Moses

|url=http://umanitoba.ca/faculties/medicine/units/medical_microbiology/faculty/StephenMoses.html

|publisher=University of Manitoba

|publisher={{UNI|University of Manitoba|UManitoba}}

|date=

|accessdate=2011-02-23

Line 80:

|last=

|first=

|publisher=Doctors Opposing Circumcision

|publisher=[[Doctors Opposing Circumcision (D.O.C.)]]

|date=2016

|title=HIV/AIDS

|url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/

|accessdate=2020-03-23

}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as HIV prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>Bailey ~~RC, Moses S, Parker CB,~~ et al~~. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. ''Lancet''~~ 2007~~;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]~~</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.

}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>{{RCT Bailey et al 2007}}</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.

Moses' research on circumcision protection from HIV infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in HIV was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.<ref>{{REFjournal

Moses' research on circumcision protection from [[HIV]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> [[Michel Garenne|Garenne]] & Matthews (2019) report that circumcised men have as much [[HIV]] infection as intact men.<ref>{{REFjournal

|last=Garenne

|init=M

|author-link=

|author-link=Michel Garenne

|last2=Matthews

|init2=A

Line 113:

== Active projects ==

* A randomized, controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya.<ref name='moses-bio'/> [[National Institutes of Health]].

* A randomized, controlled trial of male circumcision to reduce [[HIV]] incidence in Kisumu, Kenya.<ref name='moses-bio'/> [[National Institutes of Health]].

* Scaling up HIV prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Scaling up [[HIV]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Monitoring and evaluation of the Avahan project in India.<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Monitoring and evaluation of the Avahan project in [[India]].<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, [[India]].<ref name='moses-bio'/> [[Bill & Melinda Gates Foundation]].

* Mapping key populations for HIV prevention in Sri Lanka.<ref name='moses-bio'/> World Bank.

* Mapping key populations for [[HIV]] prevention in Sri Lanka.<ref name='moses-bio'/> World Bank.

~~== Recent publications ==~~

* ~~Prevalence and risk factors for human papillomavirus infection by penile site in [[uncircumcised]] Kenyan men.<ref>~~{{REFjournal

* {{REFjournal

|last=Smith

|init=JS

Line 127:

|last3=Hudgens

|init3=MG

|last4=Bailey

|first4=Robert C.

|init4=RC

|author4-link=Robert C. Bailey

|last5=Agot

|init5=K

|last6=Ndinya-Achola

|init6=JO

|last7=Moses

|init7=S

|author7-link=Stephen Moses

|etal=yes

|date=2010-01

Line 139:

Line 150:

|DOI=10.1002/ijc.24770

|accessdate=

}}~~</ref> Smith JS, Hudgens MG, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7.~~

}}

* ~~Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>~~{{REFjournal

* {{REFjournal

|last=Moses

|init=S

|author-link=Stephen Moses

|date=2009-10

|title=Male circumcision: a new approach to reducing HIV transmission

|title=Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission

|journal=CMAJ

|journal=CIHR/CMAJ

|volume=181

|issue=8

Line 155:

Line 166:

|DOI=10.1503/cmaj.090809

|accessdate=

}}~~</ref> Moses S. CIHR/CMAJ 2009; 181: E134-5.~~

}}

* ~~Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>~~{{REFjournal

* {{REFjournal

|last=Mehta

|init=SD

|last2=Gray

|init2=RH

|author2-link=Ronald H. Gray

|last3=Auvert

|init3=B

|author3-link=Bertran Auvert

|last4=Moses

|init4=S

|author4-link=Stephen Moses

|last5=Kigozi

|init5=G

|author5-link=Godfrey Kigozi

|last6=Taljaard

|init6=D

|last7=Puren

|init7=A

|last8=Agot

|init8=K

|last9=Serwadda

|init9=D

|other=Parker CB, [[Maria Wawer|Wawer MJ]], [[Robert C. Bailey|Bailey RC]]

|etal=yes

|date=2007-07

Line 176:

Line 204:

|accessdate=

}}

</ref> Mehta SD, '''[[Ronald Gray|Gray RH]]''', '''[[Bertran Auvert|Auvert B]]''', Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, '''[[Maria Wawer|Wawer MJ]]''', '''[[Robert C. Bailey|Bailey RC]]'''. AIDS 2009; 23: 1557-64.

* {{RCT Bailey et al 2007}}

* ~~Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>~~{{~~REFjournal~~

* {{REFjournal

~~|last=~~Bailey

~~|init=RC~~

~~|last2=Moses~~

~~|init2=S~~

~~|author2-link=Stephen Moses~~

~~|last3=Parker~~

~~|init3=CB~~

~~|etal=yes~~

~~|date=~~2007~~-02~~

~~|title=Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial~~

~~|journal=Lancet~~

~~|volume=369~~

~~|issue=9562~~

~~|pages=643–56~~

~~|url=~~

~~|pubmedID=17321310~~

~~|DOI=10.1016/S0140-6736(07)60312-2~~

~~|accessdate=~~

}}

~~</ref> '''[[Robert C. Bailey|Bailey RC]]''', Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56.~~

* ~~Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>~~{{REFjournal

|last=Nagelkerke

|init=NJ

|init=NJD

|last2=Moses

|init2=S

Line 208:

Line 215:

|last4=Bailey

|init4=RC

|author4-link=Robert C. Bailey

|date=2007

|title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa

Line 219:

Line 227:

|DOI=10.1186/1471-2334-7-16

|accessdate=

}}~~</ref> Nagelkerke NJD, Moses S, de Vlas S, '''[[Robert C. Bailey|Bailey RC]]'''. BMC Infect Dis 2007; 7: 16.~~

}}

* ~~Adult male circumcision outcomes: experience in a developing country setting.<ref>~~{{REFjournal

* {{REFjournal

|last=Krieger

|init=JN

|last2=Bailey

|init2=RC

|last3=~~Opeya~~

|author2-link=Robert C. Bailey

|init3=JC

|last3=Agot

|init3=K

|last4=Parker

|init4=C

|last5=Ndinya-Achola

|init5=JO

|last6=Moses

|init6=S

|author6-link=Stephen Moses

|etal=yes

|date=2007

|title=Adult male circumcision outcomes: experience in a developing country setting

|journal=Urol. Int.

|journal=Urol Int

|volume=78

|issue=3

Line 239:

Line 255:

|accessdate=

}}

~~</ref> Krieger J, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.~~

* [[Bias]]

* [[Canada]]

* [[Circumcised doctors]]

Line 253:

Line 269:

[[Category:Researcher]]

[[Category:Author]]

[[Category:Canada]]

@@ Line 55: / Line 55: @@
   |DOI=10.1111/j.1464-410X.2005.05810.x
   |accessdate=
-}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an HIV prevention method.<ref>{{REFweb
+}}</ref> which are being used by the [[World Health Organization]] (under the guide of [[UNAIDS]]) to endorse circumcision as an [[HIV]] prevention method.<ref>{{REFweb
   |last=World Health Organization
   |first=
@@ Line 65: / Line 65: @@
 == Interests ==
-According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.<ref name='moses-bio'>{{REFweb
+According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/[[HIV]] transmission.<ref name='moses-bio'>{{REFweb
   |last=Moses
   |first=Stephen
   |title=Dr. Stephen Moses
   |url=http://umanitoba.ca/faculties/medicine/units/medical_microbiology/faculty/StephenMoses.html
-  |publisher=University of Manitoba
+  |publisher={{UNI|University of Manitoba|UManitoba}}
   |date=
   |accessdate=2011-02-23
@@ Line 80: / Line 80: @@
   |last=
   |first=
-  |publisher=Doctors Opposing Circumcision
+  |publisher=[[Doctors Opposing Circumcision (D.O.C.)]]
   |date=2016
   |title=HIV/AIDS
   |url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/
   |accessdate=2020-03-23
-}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as HIV prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. ''Lancet'' 2007;369:643-56. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60312-2/abstract Abstract]</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.
+}}</ref>Of the three {{#tip-text:RCT|Randomized controlled trial}}s being used by the [[WHO]] to endorse circumcision as [[HIV]] prevention, Stephen Moses and [[Robert C. Bailey]] headed the {{#tip-text:RCT|Randomized controlled trial}} that was carried out in Kenya.<ref>{{RCT Bailey et al 2007}}</ref> Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.
-Moses' research on circumcision protection from HIV infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in HIV was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.<ref>{{REFjournal
+Moses' research on circumcision protection from [[HIV]] infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent ''relative'' reduction in [[HIV]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> [[Michel Garenne|Garenne]] & Matthews (2019) report that circumcised men have as much [[HIV]] infection as intact men.<ref>{{REFjournal
   |last=Garenne
   |init=M
-  |author-link=
+  |author-link=Michel Garenne
   |last2=Matthews
   |init2=A
@@ Line 113: / Line 113: @@
 == Active projects ==
-* A randomized, controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small>
+* A randomized, controlled trial of male circumcision to reduce [[HIV]] incidence in Kisumu, Kenya.<ref name='moses-bio'/><br><small>[[National Institutes of Health]].</small>
-* Scaling up HIV prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
+* Scaling up [[HIV]] prevention in Karnataka and southern Maharashtra, Phase II.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
-* Monitoring and evaluation of the Avahan project in India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
+* Monitoring and evaluation of the Avahan project in [[India]].<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
-* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
+* Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, [[India]].<ref name='moses-bio'/><br><small>[[Bill & Melinda Gates Foundation]].</small>
-* Mapping key populations for HIV prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small>
+* Mapping key populations for [[HIV]] prevention in Sri Lanka.<ref name='moses-bio'/><br><small>World Bank.</small>
-== Recent publications ==
+{{PUB}}
-* Prevalence and risk factors for human papillomavirus infection by penile site in [[uncircumcised]] Kenyan men.<ref>{{REFjournal
+* {{REFjournal
   |last=Smith
   |init=JS
@@ Line 127: / Line 127: @@
   |last3=Hudgens
   |init3=MG
+ |last4=Bailey
+ |first4=Robert C.
+ |init4=RC
+ |author4-link=Robert C. Bailey
+ |last5=Agot
+ |init5=K
+ |last6=Ndinya-Achola
+ |init6=JO
+ |last7=Moses
+ |init7=S
+ |author7-link=Stephen Moses
   |etal=yes
   |date=2010-01
@@ Line 139: / Line 150: @@
   |DOI=10.1002/ijc.24770
   |accessdate=
-}}</ref><br><small>Smith JS, Hudgens MG, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7.</small>
+}}
-* Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal
+* {{REFjournal
   |last=Moses
   |init=S
   |author-link=Stephen Moses
   |date=2009-10
-  |title=Male circumcision: a new approach to reducing HIV transmission
+  |title=Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission
-  |journal=CMAJ
+  |journal=CIHR/CMAJ
   |volume=181
   |issue=8
@@ Line 155: / Line 166: @@
   |DOI=10.1503/cmaj.090809
   |accessdate=
-}}</ref><br><small>Moses S. CIHR/CMAJ 2009; 181: E134-5.</small>
+}}
-* Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal
+* {{REFjournal
   |last=Mehta
   |init=SD
   |last2=Gray
   |init2=RH
+ |author2-link=Ronald H. Gray
   |last3=Auvert
   |init3=B
+ |author3-link=Bertran Auvert
+ |last4=Moses
+ |init4=S
+ |author4-link=Stephen Moses
+ |last5=Kigozi
+ |init5=G
+ |author5-link=Godfrey Kigozi
+ |last6=Taljaard
+ |init6=D
+ |last7=Puren
+ |init7=A
+ |last8=Agot
+ |init8=K
+ |last9=Serwadda
+ |init9=D
+ |other=Parker CB, [[Maria Wawer|Wawer MJ]], [[Robert C. Bailey|Bailey RC]]
   |etal=yes
   |date=2007-07
@@ Line 176: / Line 204: @@
   |accessdate=
 }}
-</ref><br><small>Mehta SD, '''[[Ronald Gray|Gray RH]]''', '''[[Bertran Auvert|Auvert B]]''', Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, '''[[Maria Wawer|Wawer MJ]]''', '''[[Robert C. Bailey|Bailey RC]]'''. AIDS 2009; 23: 1557-64.</small>
+* {{RCT Bailey et al 2007}}
-* Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal
+* {{REFjournal
- |last=Bailey
- |init=RC
- |last2=Moses
- |init2=S
- |author2-link=Stephen Moses
- |last3=Parker
- |init3=CB
- |etal=yes
- |date=2007-02
- |title=Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial
- |journal=Lancet
- |volume=369
- |issue=9562
- |pages=643–56
- |url=
- |pubmedID=17321310
- |DOI=10.1016/S0140-6736(07)60312-2
- |accessdate=
-}}
-</ref><br><small>'''[[Robert C. Bailey|Bailey RC]]''', Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56.</small>
-* Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal
   |last=Nagelkerke
-  |init=NJ
+  |init=NJD
   |last2=Moses
   |init2=S
@@ Line 208: / Line 215: @@
   |last4=Bailey
   |init4=RC
+ |author4-link=Robert C. Bailey
   |date=2007
   |title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa
@@ Line 219: / Line 227: @@
   |DOI=10.1186/1471-2334-7-16
   |accessdate=
-}}</ref><br><small>Nagelkerke NJD, Moses S, de Vlas S, '''[[Robert C. Bailey|Bailey RC]]'''. BMC Infect Dis 2007; 7: 16.</small>
+}}
-* Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal
+* {{REFjournal
   |last=Krieger
   |init=JN
   |last2=Bailey
   |init2=RC
-  |last3=Opeya
+ |author2-link=Robert C. Bailey
-  |init3=JC
+  |last3=Agot
+  |init3=K
+ |last4=Parker
+ |init4=C
+ |last5=Ndinya-Achola
+ |init5=JO
+ |last6=Moses
+ |init6=S
+ |author6-link=Stephen Moses
   |etal=yes
   |date=2007
   |title=Adult male circumcision outcomes: experience in a developing country setting
-  |journal=Urol. Int.
+  |journal=Urol Int
   |volume=78
   |issue=3
@@ Line 239: / Line 255: @@
   |accessdate=
 }}
-</ref><br><small>Krieger J, '''[[Robert C. Bailey|Bailey RC]]''', Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.</small>
 {{SEEALSO}}
 * [[Bias]]
+* [[Canada]]
 * [[Circumcised doctors]]
@@ Line 253: / Line 269: @@
 [[Category:Researcher]]
+[[Category:Author]]
 [[Category:Canada]]